Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations

Jae Jeong Lee, Ho Young Yi, Jae Won Yang, Jun Seop Shin, Jai Hyun Kwon, Chan Wha Kim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Morphological and functional changes of rat pancreatic islets caused by administration of streptozotocin (STZ) and the bioavailability of insulin formulations administered to STZ-induced diabetic rats with fasting (12 h) or non-fasting were investigated. Islets isolated from normal rats maintained a good three-dimensional structure and the islet yield was 962.5 ± 86.5 islet equivalent number (IEQ, islets converted to an average diameter of 150 μm). In the diabetic group (> 500 mg/ ml blood glucose), the islet yield was only 44.4 ± 8.3 IEQ and the islet was severely damaged. The minimum reduction of blood glucose of each formulation, such as insulin solution, microcrystal, and insulin microcrystal capsule, was shown to be 11.3, 11.0, and 16.3 mg/dl, respectively, at 6 h in fasting with diabetic rats. These results indicated that the administration of insulin formulations to the fasting groups increased the severe hypoglycemic effect of insulin action more than in non-fasting diabetic rats. The diabetic rat with fasting has a regulatory disorder in maintaining the blood glucose level. Accordingly, the validity of pharmacological availability as an optimal modeling of insulin formulations is best in non-fasting STZ-induced diabetic rats.

Original languageEnglish
Pages (from-to)2396-2401
Number of pages6
JournalBioscience, Biotechnology and Biochemistry
Volume67
Issue number11
DOIs
Publication statusPublished - 2003 Nov 1

Fingerprint

Pharmacodynamics
streptozotocin
Insulin
pharmacology
Streptozocin
Rats
insulin
rats
fasting
Fasting
blood glucose
Glucose
Blood Glucose
Microcrystals
Blood
glycemic effect
islets of Langerhans
Islets of Langerhans
Hypoglycemic Agents
Biological Availability

Keywords

  • Diabetes
  • Insulin
  • Islet
  • Pharmacodynamics
  • Streptozotocin

ASJC Scopus subject areas

  • Food Science
  • Applied Microbiology and Biotechnology
  • Chemistry (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Biotechnology
  • Bioengineering

Cite this

Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations. / Lee, Jae Jeong; Yi, Ho Young; Yang, Jae Won; Shin, Jun Seop; Kwon, Jai Hyun; Kim, Chan Wha.

In: Bioscience, Biotechnology and Biochemistry, Vol. 67, No. 11, 01.11.2003, p. 2396-2401.

Research output: Contribution to journalArticle

Lee, Jae Jeong ; Yi, Ho Young ; Yang, Jae Won ; Shin, Jun Seop ; Kwon, Jai Hyun ; Kim, Chan Wha. / Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations. In: Bioscience, Biotechnology and Biochemistry. 2003 ; Vol. 67, No. 11. pp. 2396-2401.
@article{61bf4b95aa6545c3ba6c95937a120566,
title = "Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations",
abstract = "Morphological and functional changes of rat pancreatic islets caused by administration of streptozotocin (STZ) and the bioavailability of insulin formulations administered to STZ-induced diabetic rats with fasting (12 h) or non-fasting were investigated. Islets isolated from normal rats maintained a good three-dimensional structure and the islet yield was 962.5 ± 86.5 islet equivalent number (IEQ, islets converted to an average diameter of 150 μm). In the diabetic group (> 500 mg/ ml blood glucose), the islet yield was only 44.4 ± 8.3 IEQ and the islet was severely damaged. The minimum reduction of blood glucose of each formulation, such as insulin solution, microcrystal, and insulin microcrystal capsule, was shown to be 11.3, 11.0, and 16.3 mg/dl, respectively, at 6 h in fasting with diabetic rats. These results indicated that the administration of insulin formulations to the fasting groups increased the severe hypoglycemic effect of insulin action more than in non-fasting diabetic rats. The diabetic rat with fasting has a regulatory disorder in maintaining the blood glucose level. Accordingly, the validity of pharmacological availability as an optimal modeling of insulin formulations is best in non-fasting STZ-induced diabetic rats.",
keywords = "Diabetes, Insulin, Islet, Pharmacodynamics, Streptozotocin",
author = "Lee, {Jae Jeong} and Yi, {Ho Young} and Yang, {Jae Won} and Shin, {Jun Seop} and Kwon, {Jai Hyun} and Kim, {Chan Wha}",
year = "2003",
month = "11",
day = "1",
doi = "10.1271/bbb.67.2396",
language = "English",
volume = "67",
pages = "2396--2401",
journal = "Bioscience, Biotechnology and Biochemistry",
issn = "0916-8451",
publisher = "Japan Society for Bioscience Biotechnology and Agrochemistry",
number = "11",

}

TY - JOUR

T1 - Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations

AU - Lee, Jae Jeong

AU - Yi, Ho Young

AU - Yang, Jae Won

AU - Shin, Jun Seop

AU - Kwon, Jai Hyun

AU - Kim, Chan Wha

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Morphological and functional changes of rat pancreatic islets caused by administration of streptozotocin (STZ) and the bioavailability of insulin formulations administered to STZ-induced diabetic rats with fasting (12 h) or non-fasting were investigated. Islets isolated from normal rats maintained a good three-dimensional structure and the islet yield was 962.5 ± 86.5 islet equivalent number (IEQ, islets converted to an average diameter of 150 μm). In the diabetic group (> 500 mg/ ml blood glucose), the islet yield was only 44.4 ± 8.3 IEQ and the islet was severely damaged. The minimum reduction of blood glucose of each formulation, such as insulin solution, microcrystal, and insulin microcrystal capsule, was shown to be 11.3, 11.0, and 16.3 mg/dl, respectively, at 6 h in fasting with diabetic rats. These results indicated that the administration of insulin formulations to the fasting groups increased the severe hypoglycemic effect of insulin action more than in non-fasting diabetic rats. The diabetic rat with fasting has a regulatory disorder in maintaining the blood glucose level. Accordingly, the validity of pharmacological availability as an optimal modeling of insulin formulations is best in non-fasting STZ-induced diabetic rats.

AB - Morphological and functional changes of rat pancreatic islets caused by administration of streptozotocin (STZ) and the bioavailability of insulin formulations administered to STZ-induced diabetic rats with fasting (12 h) or non-fasting were investigated. Islets isolated from normal rats maintained a good three-dimensional structure and the islet yield was 962.5 ± 86.5 islet equivalent number (IEQ, islets converted to an average diameter of 150 μm). In the diabetic group (> 500 mg/ ml blood glucose), the islet yield was only 44.4 ± 8.3 IEQ and the islet was severely damaged. The minimum reduction of blood glucose of each formulation, such as insulin solution, microcrystal, and insulin microcrystal capsule, was shown to be 11.3, 11.0, and 16.3 mg/dl, respectively, at 6 h in fasting with diabetic rats. These results indicated that the administration of insulin formulations to the fasting groups increased the severe hypoglycemic effect of insulin action more than in non-fasting diabetic rats. The diabetic rat with fasting has a regulatory disorder in maintaining the blood glucose level. Accordingly, the validity of pharmacological availability as an optimal modeling of insulin formulations is best in non-fasting STZ-induced diabetic rats.

KW - Diabetes

KW - Insulin

KW - Islet

KW - Pharmacodynamics

KW - Streptozotocin

UR - http://www.scopus.com/inward/record.url?scp=3242883645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242883645&partnerID=8YFLogxK

U2 - 10.1271/bbb.67.2396

DO - 10.1271/bbb.67.2396

M3 - Article

C2 - 14646199

AN - SCOPUS:3242883645

VL - 67

SP - 2396

EP - 2401

JO - Bioscience, Biotechnology and Biochemistry

JF - Bioscience, Biotechnology and Biochemistry

SN - 0916-8451

IS - 11

ER -